Evidence map›Paper›PMID 24431446›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice.

Denggao Yao, Rhona McGonigal, Jennifer A Barrie, Joanna Cappell, Madeleine E Cunningham, Gavin R Meehan, Simon N Fewou, Julia M Edgar, Edward Rowan, Yuhsuke Ohmi and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Functional evaluation of novel variants ofFrontiers in neuroscience · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. A Compound Heterozygous Pathogenic Variant inJournal of clinical neurology (Seoul, Korea) · 2021
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Glial Sulfatides and Neuronal Complex Gangliosides Are Functionally Interdependent in Maintaining Myelinating Axon Integrity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  15. Article
  16. Gangliosides of the Vertebrate Nervous System.Journal of molecular biology · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Denggao YaoInstitute of Infection, Immunity, and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8TA, United Kingdom, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0NR, United Kingdom, Department of Biochemistry II, Nagoya University School of Medicine, Nagoya 466-0065, Japan, and Centre for Neuroregeneration, University of Edinburgh, Edinburgh EH16 4SB, United Kingdom.
Rhona McGonigal
Jennifer A Barrie
Joanna Cappell
Madeleine E Cunningham
Gavin R Meehan
Simon N Fewou
Julia M Edgar
Edward Rowan
Yuhsuke Ohmi
Keiko Furukawa
Koichi Furukawa
Peter J Brophy
Hugh J Willison
Institute of Infection and Immunity · CANagoya University · JPUniversity of Glasgow · GBUniversity of Strathclyde · GBWellcome Centre for Molecular Parasitology · GB

Funding

Wellcome TrustWellcome Trust 092805
6 · The paper itself

Abstract

Gangliosides are widely expressed sialylated glycosphingolipids with multifunctional properties in different cell types and organs. In the nervous system, they are highly enriched in both glial and neuronal membranes. Mice lacking complex gangliosides attributable to targeted ablation of the B4galnt1 gene that encodes β-1,4-N-acetylegalactosaminyltransferase 1 (GalNAc-transferase; GalNAcT(-/-)) develop normally before exhibiting an age-dependent neurodegenerative phenotype characterized by marked behavioral abnormalities, central and peripheral axonal degeneration, reduced myelin volume, and loss of axo-glial junction integrity. The cell biological substrates underlying this neurodegeneration and the relative contribution of either glial or neuronal gangliosides to the process are unknown. To address this, we generated neuron-specific and glial-specific GalNAcT rescue mice crossed on the global GalNAcT(-/-) background [GalNAcT(-/-)-Tg(neuronal) and GalNAcT(-/-)-Tg(glial)] and analyzed their behavioral, morphological, and electrophysiological phenotype. Complex gangliosides, as assessed by thin-layer chromatography, mass spectrometry, GalNAcT enzyme activity, and anti-ganglioside antibody (AgAb) immunohistology, were restored in both neuronal and glial GalNAcT rescue mice. Behaviorally, GalNAcT(-/-)-Tg(neuronal) retained a normal "wild-type" (WT) phenotype throughout life, whereas GalNAcT(-/-)-Tg(glial) resembled GalNAcT(-/-) mice, exhibiting progressive tremor, weakness, and ataxia with aging. Quantitative electron microscopy demonstrated that GalNAcT(-/-) and GalNAcT(-/-)-Tg(glial) nerves had significantly increased rates of axon degeneration and reduced myelin volume, whereas GalNAcT(-/-)-Tg(neuronal) and WT appeared normal. The increased invasion of the paranode with juxtaparanodal Kv1.1, characteristically seen in GalNAcT(-/-) and attributed to a breakdown of the axo-glial junction, was normalized in GalNAcT(-/-)-Tg(neuronal) but remained present in GalNAcT(-/-)-Tg(glial) mice. These results indicate that neuronal rather than glial gangliosides are critical to the age-related maintenance of nervous system integrity.

Indexed as

Gene Expression Regulation, EnzymologicPhenotypeAgingAnimalsAxonsGangliosidesMaleMiceMice, KnockoutMice, TransgenicN-AcetylgalactosaminyltransferasesNeurodegenerative DiseasesNeuronsPolypeptide N-acetylgalactosaminyltransferaseGangliosidesN-AcetylgalactosaminyltransferasesPolypeptide N-acetylgalactosaminyltransferasegangliosideglycosyltransferaseneurodegenerationtransgenic

Identifiers

PMID24431446
PMCPMC3891965
OpenAlexW2047298772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.